WuXi Biologics (Cayman)

(OTC) WXXWY

Current Price$7.89

Market Cap$16.34B

Since IPO (2017)+123%

5 Year-75%

1 Year+11%

1 Month-9%

WuXi Biologics (Cayman) Financials at a Glance

Market Cap

$16.34B

Revenue (TTM)

CN¥40.25B

Net Income (TTM)

CN¥8.22B

EPS (TTM)

$0.32

P/E Ratio

23.57

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$7.89

Volume

35,679

Open

$8.24

Price

$7.89

Volume

35,679

Open

$8.24

Previous Close

$7.89

Daily Range

$7.62 - $8.24

52-Week Range

$6.02 - $11.21

Estimated Earnings Date

Aug 26, 2026

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$7.89

Volume

35,679

Open

$8.24

Previous Close

$7.89

Daily Range

$7.62 - $8.24

52-Week Range

$6.02 - $11.21

Estimated Earnings Date

Aug 26, 2026

WXXWY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About WuXi Biologics (Cayman)

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

13,252

CEO

Zhi Sheng Chen, PhD

Website

www.wuxibiologics.com

Headquarters

Wuxi, 214092, CN

WXXWY Financials

Key Financial Metrics (TTM)

Gross Margin

46%

Operating Margin

30%

Net Income Margin

23%

Return on Equity

11%

Return on Capital

12%

Return on Assets

Earnings Yield

4.24%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.34B

Shares Outstanding

2.07B

Volume

35.68K

Avg. Volume

82.91K

Financials (TTM)

Gross Profit

CN¥9.75B

Operating Income

CN¥6.47B

EBITDA

CN¥8.16B

Operating Cash Flow

CN¥6.38B

Capital Expenditure

-CN¥3.58B

Free Cash Flow

CN¥2.79B

Cash & ST Invst.

CN¥15.75B

Total Debt

CN¥3.11B

WuXi Biologics (Cayman) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

CN¥11.62B

+36.0%

Gross Profit

CN¥5.66B

+73.2%

Gross Margin

48.71%

N/A

Market Cap

$16.34B

N/A

Market Cap/Employee

$1.30M

N/A

Employees

12,575

N/A

Net Income

CN¥2.52B

+122.6%

EBITDA

CN¥4.72B

+108.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

CN¥15.75B

+40.1%

Total Debt

CN¥3.11B

-31.9%

Accounts Receivable

CN¥8.90B

+43.9%

Inventory

CN¥1.44B

-18.4%

Long Term Debt

CN¥1.85B

-51.7%

Short Term Debt

CN¥1.26B

+71.8%

Return on Assets

7.70%

N/A

Return on Invested Capital

11.98%

N/A

Free Cash Flow

CN¥2.79B

+1174.1%

Operating Cash Flow

CN¥4.59B

+96.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RXDXPrometheus Biosciences, Inc.

RXDXPrometheus Biosciences, Inc.$199.92+0.09%

NUVLNuvalent, Inc.

NUVLNuvalent, Inc.$123.25-0.16%

CORTCorcept Therapeutics Incorporated

CORTCorcept Therapeutics Incorporated$82.91-0.41%

PRAXPraxis Precision Medicines, Inc.

PRAXPraxis Precision Medicines, Inc.$266.58+7.50%

SNDXSyndax Pharmaceuticals, Inc.

SNDXSyndax Pharmaceuticals, Inc.$18.25+1.90%

EQRXEQRx, Inc.

EQRXEQRx, Inc.$2.34-2.09%

RAPTRAPT Therapeutics, Inc.

RAPTRAPT Therapeutics, Inc.$58.01+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

INTCIntel

INTCIntel$124.57+0.07%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

Questions About WXXWY

What is the current price of WuXi Biologics (Cayman)?

WuXi Biologics (Cayman) is trading at $7.89 per share.

What is the 52-week range for WuXi Biologics (Cayman)?

Over the past 52 weeks, WuXi Biologics (Cayman) has traded between $6.02 and $11.21.

How much debt does WuXi Biologics (Cayman) have?

As of the most recent reporting period, WuXi Biologics (Cayman) reported total debt of CN¥444.19M.

How much cash does WuXi Biologics (Cayman) have on hand?

WuXi Biologics (Cayman) reported CN¥1.32B in cash and cash equivalents in its most recent financial results.

What is WuXi Biologics (Cayman)’s dividend yield?

WuXi Biologics (Cayman) does not currently have a dividend yield.

WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Financials at a Glance

WXXWY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About WuXi Biologics (Cayman)

WXXWY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

WuXi Biologics (Cayman) Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About WXXWY

What is the current price of WuXi Biologics (Cayman)?

What is the 52-week range for WuXi Biologics (Cayman)?

How much debt does WuXi Biologics (Cayman) have?

How much cash does WuXi Biologics (Cayman) have on hand?

What is WuXi Biologics (Cayman)’s dividend yield?

Premium Investing Services